HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 216967Erstellt: 26. Oktober 2026
Sodium Carbonate → (S)-tert-Butyl 4-(1-amino-3-(4-(4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazin-7-yl)phenyl)-1-oxopropan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate
https://huagongshe.com/reaction/216967
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Sodium Carbonate | HCID 10340 | — |
| Edukt | 7-Bromo-2H-(1,4)-benzothiazin-3(4h)-one | HCID 689065 | — |
| Edukt | (S)-tert-Butyl 4-(1-amino-1-oxo-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate | HCID 59568592 | — |
| Lösungsmittel | Acetonitrile | HCID 6342 | — |
| Produkt | (S)-tert-Butyl 4-(1-amino-3-(4-(4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazin-7-yl)phenyl)-1-oxopropan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate | HCID 59568625 | — |
Reaktionsschritte
(S)-tert-Butyl 4-(1-amino-1-oxo-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (Example 16, step (i), 241 mg) in acetonitrile (8 mL) with 7-bromo-4-methyl-2H-benzo[b][1,4]thiazin-3(4H)-one (Example 28, step (i), 120 mg) was treated with aqueous sodium carbonate solution (2M, 0.465 mL) and then nitrogen was bubbled through the mixture. 1,1 bis(Di-tert-butylphosphino)ferrocene palladium dichloride (5 mg) was added and the mixture was heated at 85° C. under nitrogen for 18 h. A further addition of sodium carbonate solution (2M, 0.2 mL) and 1,1 bis(di-tert-butylphosphino)ferrocene palladium dichloride (5 mg) was made and the mixture was heated at 85° C. for a further 18 h. A further addition of (S)-tert-butyl 4-(1-amino-1-oxo-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (Example 16, step (i), 20 mg) was made and the mixture was heated at 85° C. for 18 h. The mixture was purified by chromatography on silica eluting with ethyl acetate/isohexane (50:50 to 100:0) to afford the sub-titled compound (132 mg).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08193239B2 |
|---|
| Quelldatensatz | uspto-grants-2012_06 |
|---|
| ORD ID | ord-e16f060404284ef8bfbac929dae84aee |
|---|
| Quellennotiz | uspto-grants-2012_06 |
|---|